medigraphic.com

2014, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (S1)

Characterization of obese children with and without metabolic syndrome in a pediatric hospital

Ortega-Cortés R, Hurtado-López EF, López-Beltrán AL, Trujillo-Trujillo XAR, Tlacuilo-Parra JA, Colunga-Rodríguez C

Language: Spanish
References: 40
Page: 48-57
PDF size: 214.76 Kb.


ABSTRACT

Background: The alterations caused by metabolic syndrome (MS) arise progressively throughout the years, but they can start at a pediatric age. The objective of this paper was to evaluate the biochemical and clinical characteristics of obese children with or without MS.
Methods: Descriptive cross-sectional study, in which we analyzed, according to the 2010 classifi cation of the Centers for Disease Control and Prevention (CDC), 103 obese children between 10 and 15 years from an endocrinology service. The variables were weight, size, body mass index (BMI), waist circumference (WC), glucose, HDL cholesterol, triglycerides, blood pressure, insulin, and HOMA. Means were compared statistically with Student’s t test, and Mann-Whitney U.
Results: Of 103 patients, 55 showed criteria for MS (53.3 %) and 48 incomplete criteria for MS (46.6 %). In the group without MS, 60.4 and 64.5 % showed insulin resistance and hyperinsulinemia, respectively. In all the group, 28.1 % showed arterial hypertension, and 23.3 % prehypertension. With regards to the means of other parameters that does not belong to the MS, we obtained weight (p = 0.008), BMI (p = 0.009), insulin (p = 0.027) and HOMA (p = 0.023). More than 60 % showed pre-diabetes and almost 50 % blood pressure alterations.
Conclusion: It is urgent to perform a screening in obese children, as well as an awareness campaign in mass media, in order to spread the gravity of the problem and trigger the search of medical help, and of health professionals to establish their diagnosis.


REFERENCES

  1. Robles VC. Riesgo cardiovascular y síndrome metabólico en niños y adolescentes. Acta Pediatr Mex. 2011;32(1):1-4. Disponible en http://www. intramed.net/userfi les/2011/fi le/Mexico/Acta%25201 _2%2520EDITORIAL(1).pdf

  2. Durán P, Piazza N, Trifone L. Consenso sobre factores de riesgo de obesidad y enfermedad cardiovascular en pediatría. Arch Arg Pediatr. 2005;103(3):262-81.

  3. González CA, Lavalle GF, Rios GJ. Síndrome metabólico y enfermedad cardiovascular. 3ª ed. México: Intersistemas; 2009: 23-24.

  4. Acosta G. Vigencia del síndrome metabólico. Acta Bioquím Clín Latinoam. 2011;45(3):423-30.

  5. Muñoz CMT. Síndrome metabólico. Pediatr Integral. 2007;7:615-22.

  6. Moya M. Comórbidos de la obesidad pediátrica y del adolescente. Un enfoque facilitador de su diagnostico: el síndrome metabólico. Ann Pediatr (Barc). 2011;74(5): 289-92.

  7. Barja S, Acevedo M, Arnaiz P, Berrios X, Bambs C, Guzmán B, et al. Marcadores de aterosclerosis temprana y síndrome metabólico en niños. Rev Med Chile. 2009;137(4):522-30.

  8. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientifi c statement from the American Heart Association Atherosclerosis, hypertension, and obesity in the young committee of the council on cardiovascular disease in the young; council on cardiovascular nursing: and council on nutrition, physical activity, and metabolism. Circulation. 2009;119(4): 628-47.

  9. Martínez BA, Maldonado HJ, López AM. Métodos diagnósticos de la resistencia a la insulina en la población pediátrica. Bol Med Hosp Inf Mex. 2011; 68(5):397-404.

  10. Pérez MM, Montoya ME. Técnicas para el estudio de la resistencia insulínica. Una valoración crítica. Ann Diabetol. 2001;17:179-86.

  11. Frenk BP, Márquez E. Diabetes mellitus tipo 2 en niños y adolescentes. Med Int Mex. 2010;26(1):36-47.

  12. Miranda PJ, Defronzo R, Califf R, Guyton JR. Metabolic syndrome: defi nition, pathophysiology, and mechanisms. Am Heart J. 2005;149(1):33-45.

  13. Castillo ML, Orea TA. Obesidad en pediatría. Mexico: Intersistemas. 2009;1-7.

  14. Steinberger J, Daniels S. Obesity, insulin resistance, diabetes and cardiovascular risk in children: An American Heart Association Scientifi c Statement from the Atherosclerosis, hypertension, and obesity in the young committee (Council on nutrition, physical activity, and metabolism). Circulation. 2003:107(10):1448-53.

  15. Brambila P, Lissau I, Flodmark CE, Moreno LA, Widhalm K, Wabitsch M, et al. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes (Lond). 2007;31(4):591-600.

  16. Laclaustra GM, Bergua MC, Pascual CI, Casasnovas LJ. Síndrome metabólico. Concepto y fi siopatología. Rev Esp Cardiol Supl. 2005;5(D):3-10.

  17. D’Adamo E, Santoro N, Caprio S. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. Endocrinol Metab Clin North Am. 2009; 38(3):549-63.

  18. Lerman G, Aguilar SC, Gómez PF, Reza AA, Hernández JS, Vázquez CC. et al. El síndrome metabólico: características del síndrome metabólico en México. Rev Endocrin Nutric. 2004;12(3):109-122.

  19. Reyes HD, Reyes HU, Sánchez CNP, Alonso RC, Reyes GU, Toledo RMI et al. Alimentos contenidos en loncheras de niños que acuden a preescolar. Bol Clin Hosp Infant Edo Son. 2010;27(1):35-40.

  20. Aradillas GC, de la Cruz ME, Torres RB, Montreal EE, Torres RL, Goldaracena AM. El impacto de la televisión sobre la prevalencia del síndrome metabólico en población infantil de San Luis Potosí. Bioquímica. 2008;33(1):10-18.

  21. Jiménez AA, Flores M, Shama LT. Sugar-sweetened beverages consumption and BMI in Mexican adolescents. Mexican National Health and Nutrition Survey 2006. Salud Pub Mex. 2009;51 supl 4:s604-12.

  22. Moya M. Comórbidos de la obesidad pediátrica y del adolescente. Un enfoque facilitador de su diagnostico: el síndrome metabólico. Ann Pediatr (Barc). 2011;74(5):289-92.

  23. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence and demographic disparities in the World Health Organization and national cholesterol education program adult treatment. Panel III, defi nitions of metabolic syndrome among adolescents. J Pediatr. 2004;145(4):445-51.

  24. Kaufer M, Toussaint G. Indicadores antropométricos para evaluar sobrepeso y obesidad en pediatría. Bol Med Hosp Infant Mex. 2008; 65;502-18.

  25. Balas NM, Villanueva QA, Tawil DS, Schiffman SE, Suverza FA, Vadillo OF et al. Estudio piloto para la identifi cación de indicadores antropométricos asociados a marcadores de riesgo de síndrome metabólico en escolares mexicanos. Bol Med Hosp Infant Mex. 2008;65(2):100-9.

  26. Pimentel FA, De Toledo NO, De Franca NM. Asociación del índice de masa corporal y de la resistencia a la insulina con síndrome metabólico en niños brasileños. Arq Bras Cardiol. 2009;93(2):144-50.

  27. Lee S, Bacha F, Gungor N, Arslanian S. Comparison of different defi nitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and infl ammatory markers. J Pediatr. 2008; 152(2):177-84.

  28. Shaibi GQ, Goran MI. Examining metabolic syndrome defi nitions in overweight hispanic youth: a focus on insulin resistance. J Pediatr. 2008;152(2):171-6.

  29. Zimmet P, Alberti KG, Kaufmann F, Tajima N, Arslanian S, Silink M, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diab. 2007;8(5):299-306.

  30. Zimmet P, Alberti G, Kaufmann F, Tajima N. Silink M, Arslanian S. et. al. The metabolic syndrome in children and adolescents. Lancet. 2007;369(9579):2059-61.

  31. Artola M, Duelo M, Escribano C. Síndrome metabólico. Rev Pediatr Aten Prim. 2009;11(Supl 16): s259-77.

  32. González FP, Cabrera RE, Oti Gli MA. Resistencia a la insulina e historia familiar en niños y adolescentes obesos con acantosis nigricans y sin ella. Rev Cub Endocrin. 2011;22(3):210-24.

  33. Coyote Estrada N. VII. Trastornos de la alimentación. Obesidad en niños. Gac Méd Méx. 2009;145(4):313-7. Texto libre http://www.anmm.org.mx/GMM/2009/ n4/49_vol_145_n4.pdf

  34. Rivera DJ, Hernández AM, Aguilar SC, Vadillo OF, Murayama RC. Obesidad en México: recomendaciones para una política de estado. México, DF: Academia Nacional de Medicina, UNAM; 2013.

  35. Tailor AM, Peeters PH, Norat T, Vineis P, Romaguera D. An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Pediatr Obes. 2010;5(3):202-13.

  36. Shamah L, Villalpando HS, Rivera Dommarco J. Manual de procedimientos para proyectos de nutrición. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2006.

  37. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics. 2012;129(6):1035-41.

  38. Hirschler V, Calcagno ML, Aranda C, Maccallini G, Jadzinsky M. Can the metabolic syndrome identify children with insulin resistance? Pediatr Diabetes. 2007;8(5):272-7.

  39. Villalpando S, Carrion C, Barquera S, Olaiz FG, Robledo R. Body mass index associated with hyperglycemia and alterations of components of metabolic syndrome in Mexican adolescents. Salud Pub Mex. 2007;49(3):324-30.

  40. Lee S, Bacha F, Silva AA. Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr. 2006;149(6):809-16.




2020     |     www.medigraphic.com